In bone, miR-451a represses the malignant progression towards osteosarcoma via blocking YTHDC1-mediated m6A methylation of PDPK1 (an activator of AKT), and subsequently inhibiting AKT/mTOR pathway. This evidence concerns the gene AKT1 and osteosarcoma.